Please login to your online account to display your discounted pricing

anti-NLRP2/NALP2, Polyclonal, Novus Biologicals™


Manufacturer: novus biologicals canada  NBP224550SS

 View more versions of this product

 Disclaimers

For Research Use Only

Catalog No. NBP224550SS

  • / Each
 

Description & Specifications

Specifications

Monoclonal or Polyclonal Polyclonal
Gene Accession No. Q9NX02
Concentration 0.5mg/mL
Conjugate Unlabeled
Gene ID (Entrez) 55655
Format Affinity Purified
Applications Immunohistochemistry (Paraffin)
Applications Western Blotting
Immunogen A portion of amino acids 130-180 of human NALP2 was used as the immunogen.
Formulation 100μg in 200μL PBS containing 0.05% BSA
Test Specificity The amino acid sequence used as immunogen is 100% homologous in human (isoforms CRA_a) and chimpanzee, 95% homologous in monkey, horse and cow, 90% homologous in dog and 80% homologous in mouse, rat and xenopus.
Primary or Secondary Primary
Cross Reactivity Human
Quantity 0.025mg
Regulatory Status RUO
Antigen NLRP2/NALP2
Host Species Rabbit